The physical sequelae of perinatally acquired HIV in adolescents: a research proposal

被引:4
作者
Comley-White, Nicolette [1 ]
Potterton, Joanne [1 ]
Ntsiea, Veronica [1 ]
机构
[1] Univ Witwatersrand, Dept Physiotherapy, Sch Therapeut Sci, Fac Hlth Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa
关键词
Adolescents; HIV; Perinatally infected; Physical;
D O I
10.1186/s13104-019-4079-5
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: As the global access of antiretrovirals for HIV-infected infants improves, so the body of perinatally HIV-infected adolescents (PHIVA) grows. The neurological and physical complications of HIV, both in children and in adults, are well established, however there is a paucity of data pertaining to PHIVA, a group of people who have had a lifetime exposure to the virus and to antiretrovirals. There has been a resounding call for further research in this area, as well as for the development of policies and programmes for this population. The aim of this study is to determine the physical sequelae in PHIVA and to propose a model of care for this population. Methods: Through interviews with PHIVA, the perceived physical challenges will be established. Thereafter a cohort study with age-matched participants will determine if PHIVA have any limitations in fatigue, endurance, motor function and muscle strength, body mass index, peripheral neuropathy, level of disability and quality of life. Using these results, a model of care will be proposed through the nominal group technique with both PHIVA and clinicians working in HIV and adolescence.
引用
收藏
页数:6
相关论文
共 43 条
  • [1] UNAIDS Data 2017
  • [2] Health for the World's Adolescents: A Second Chance in the Second Decade. 2014
  • [3] Turning the Tide Against AIDS Will Require More Concentrated Focus on Adolescents and Young People, (2017)
  • [4] Sohn A.H., Hazra R., The changing epidemiology of the global paediatric HIV epidemic: Keeping track of perinatally HIV-infected adolescents, J Int AIDS Soc, 16, (2013)
  • [5] Weiss B., Vulnerability of children and the developing brain to neurotoxic hazards, Environ Health Perspect, 108, pp. 375-381, (2000)
  • [6] Dobbing J., Vulnerable periods in developing brain, Brain, Behaviour, and Iron in the Infant Diet, pp. 1-17, (1990)
  • [7] Strazza M., Pirrone V., Wigdahl B., Nonnemacher M.R., Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier, Brain Res, 1399, pp. 96-115, (2011)
  • [8] Blokhuis C., Kootstra N., Caan M., Pajkrt D., Neurodevelopmental delay in pediatric HIV/AIDS: Current perspectives, Neurobehav HIV Med, 7, pp. 1-13, (2016)
  • [9] Shubber Z., Calmy A., Andrieux-Meyer I., Vitoria M., Renaud-Thery F., Shaffer N., Et al., Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: A systematic review and meta-analysis, AIDS, 27, pp. 1403-1412, (2013)
  • [10] Carr A., Cooper D.A., Adverse effects of antiretroviral therapy, Lancet, 356, pp. 1423-1430, (2000)